News
On June 25, Gilead Sciences expanded its oncology pipeline through an exclusive agreement with Kymera Therapeutics Inc.
In observance of National HIV Testing Day Friday, several sites across South Florida are offering free rapid HIV testing and ...
In Philadelphia, the leading causes of death are heart disease, cancer, and unintentional drug overdose. While some of these ...
The Supreme Court on Friday granted the HIV-prevention field a historic win — yet with a major caveat — as it upheld a ...
The Supreme Court upheld free preventive care, rejecting a challenge that threatened coverage for STI testing, cancer ...
Labcorp (LH), and Gilead (GILD) rise as Supreme Court upholds right to free preventive care under Obamacare. Read more here.
(Reuters) -Shares of Gilead rose nearly 3% after the U.S. Supreme Court on Friday preserved a key element of the Obamacare law that helps guarantee that health insurers cover preventive care at no ...
An injection that can prevent HIV infection for six months has been approved by the US Food and Drug Administration (FDA).
Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...
As Obergefell v Hodges turns 10 years, LGBTQ+ rights face renewed threats amid political shifts, impacting health care equity ...
The Statistical Center for HIV/AIDS Research and Prevention (SCHARP), located at Fred Hutch Cancer Center, is a statistical and data management center (SDMC) dedicated to supporting investigators who ...
The US Food and Drug Administration (FDA) has approved lenacapavir as a long-acting injectable drug to prevent HIV.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results